Sheel Biotech Limited Appoints Satbir Singh as Chief Financial Officer
Sheel Biotech Limited has appointed Mr. Satbir Singh as its Chief Financial Officer (CFO) and Key Managerial Personnel. The appointment was formalized by the Board of Directors during a meeting held on July 3, 2026, based on recommendations from the Nomination and Remuneration Committee and the Audit Committee.Mr. Satbir Singh assumes the role effective immediately, bringing extensive experience in financial management to the company.
A seasoned finance professional, Mr. Satbir Singh is a Chartered Accountant with over 16 years of expertise across various facets of corporate finance and accounting. His core competencies cover financial planning and reporting, budgeting, MIS reporting, internal controls implementation, and statutory compliance.
The appointment brings significant specialized knowledge in areas such as finalization of accounts, direct and indirect tax compliance, and treasury and working capital management. Mr. Singh possesses a proven track record in leading finance functions, optimizing financial controls, and driving operational excellence through effective process improvements.
Key details regarding the appointed Chief Financial Officer are presented below:
| Disclosure Requirement | Details |
|---|---|
| Reason for Change | Appointment of Mr. Satbir Singh as CFO of the Company. |
| Date of Appointment | July 3, 2026. |
| Professional Profile | Chartered Accountant with over 16 years experience in finance, accounting, taxation, audit, and related corporate compliance. Expertise includes financial planning & reporting, budgeting, MIS reporting, internal controls, and statutory compliance. Core competencies include finalization of accounts, direct and indirect tax compliance, treasury and working capital management. |
SHEEL Stock Price Movement
Sheel Biotech Limited shed value in the market today, slipping by 4.17% to settle at ₹68.9 after trading closed. The stock recorded a total traded volume of 2,000 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.